原发与继发性神经淋巴瘤病:神经临床、电生理与病理特征比较
该回顾性研究于1992年1月1日至2020年6月31日纳入58例经神经病理确诊的神经淋巴瘤病(NL)患者(原发PNL 34例、继发SNL 24例),比较两组临床、电生理和病理特征。PNL从神经症状起病到诊断的时间更长(18.5个月 vs SNL 5.5个月,p=0.01),SNL更多见单神经病(n=8 vs n=1,p=0.01),MRI检出率高于FDG-PET/CT(86% vs 60%,p=0.007),SNL轴索变性及多灶性有髓纤维丢失更显著,且识别SNL虽改变治疗但预后更差(p=0.025)。
要点
- PNL从神经症状起病到诊断的时间为18.5个月,长于SNL的5.5个月(p=0.01)。
- SNL单神经病数目(n=8)多于PNL(n=1)(p=0.01),MRI检出NL(86%)高于FDG-PET/CT(60%)(p=0.007)。
- SNL较PNL轴索变性(p=0.01)和多灶性有髓纤维丢失(p=0.04)更显著,识别SNL改变治疗但预后更差(p=0.025)。
核心结论
- PNL与SNL均主要表现为疼痛性、非对称性神经病,电生理和神经活检可见轴索和脱髓鞘特征,但SNL表现有所不同,呈暴发性、非对称性、常为单神经病,MRI较FDG-PET/CT更易检出。
研究设计与样本
- 回顾性研究,纳入1992年1月1日至2020年6月31日经神经病理确诊的NL患者58例(PNL 34例,SNL 24例),收集临床特征、神经系统检查、影像学、EMG和神经活检资料并比较两组。
主要发现
- PNL从神经症状起病到诊断的时间为18.5个月,SNL为5.5个月(p=0.01)。
- 两组神经症状相似,主要包括感觉丧失(98%)、严重疼痛(76%)和非对称性无力(76%)。
- SNL单神经病数目(n=8)多于PNL(n=1)(p=0.01)。
- MRI检出NL(86%)高于FDG-PET/CT(60%)(p=0.007)。
- 神经活检显示B细胞淋巴瘤(PNL n=32,SNL n=22)和T细胞淋巴瘤(PNL n=2,SNL n=2),SNL较PNL轴索变性(p=0.01)和多灶性有髓纤维丢失(p=0.04)更显著。
关键数值与推荐
- PNL从神经症状起病到诊断的时间为18.5个月,SNL为5.5个月(p=0.01)。
- SNL单神经病数目为n=8,PNL为n=1(p=0.01)。
- MRI检出NL的比例为86%,FDG-PET/CT为60%(p=0.007)。
- SNL较PNL轴索变性更显著(p=0.01),多灶性有髓纤维丢失更显著(p=0.04)。
- 识别SNL后患者治疗改变,但预后较PNL更差(p=0.025)。
临床怎么用
- 作者指出,识别SNL很重要,因为每个SNL病例的治疗和管理均因此改变。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Neurolymphomatosis (NL) is characterized by lymphomatous infiltration of the peripheral nervous system presenting as the initial manifestation of a lymphoma (primary NL [PNL]) or in relapse of a known lymphoma (secondary NL [SNL]). This report details and compares the neurologic clinicopathologic characteristics of these 2 groups. METHODS: This retrospective study was performed on patients diagnosed with pathologically confirmed NL in nerve between January 1, 1992, and June 31, 2020. Patient clinical characteristics, neurologic examination, imaging studies, EMG, and nerve biopsy data were collected, analyzed, and compared between PNL and SNL. RESULTS: A total of 58 patients were identified (34 PNL and 24 SNL). Time from neurologic symptom onset to diagnosis was longer in PNL at 18.5 months compared with 5.5 months in SNL (p = 0.01). Neurologic symptoms were similar in both patient groups and included primarily sensory loss (98%), severe pain (76%), and asymmetric weakness (76%). A wide spectrum of EMG-confirmed different neuropathy patterns were observed, but patients with SNL had increased numbers of mononeuropathies (n = 8) compared with PNL (n = 1, p = 0.01). MRI studies detected NL more frequently (86%) compared with fluorodeoxyglucose (FDG)-PET CT imaging studies (60%) (p = 0.007). Nerve biopsies revealed B-cell lymphoma (PNL n = 32, SNL n = 22), followed by T-cell lymphoma (PNL n = 2, SNL n = 2), with increased demyelination in both groups and increased axonal degeneration (p = 0.01) and multifocal myelinated fiber loss (p = 0.04) significant in SNL vs PNL. Identifying SNL resulted in patient treatment modifications but a worse prognosis compared with PNL (p = 0.025). DISCUSSION: While PNL and SNL are both primarily painful and asymmetric neuropathies with axonal and demyelinating features on EMG and nerve biopsy, SNL presents somewhat differently than PNL with fulminant, asymmetric often mononeuropathies better detected on MRI than FDG-PET/CT. The focal pattern of SNL is likely a result of residual cancer cells that evaded initial chemotherapy, which does not cross the blood-nerve barrier, and these cells can later recur and result in fulminant disease. Although still resulting in a poorer prognosis, identifying SNL is important because this changed treatment and management in every SNL case.
引用
- Skolka MP, Suanprasert N, Martinez-Thompson JM, et al. Neurologic Clinical, Electrophysiologic, and Pathologic Characteristics of Primary vs Secondary Neurolymphomatosis. Neurology. 2024. PMID: 39226481. doi:10.1212/WNL.0000000000209777
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。